Income Taxes - Additional Information (Details) - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Income Tax Contingency [Line Items]
Deferred tax assets, valuation allowance	$ 23,085,000	$ 10,618,000
Change in valuation allowance	$ 12,500,000
Percentage of federal net operating losses used to offset of future taxable income	80.00%
Penalties and Interest Accrued	$ 0
Domestic Country [Member]
Income Tax Contingency [Line Items]
Tax loss carryforwards	46,000,000.0
Net operating loss carryforwards	46,000,000.0
Tax credit carryforward	$ 2,700,000
Research and development credit carryforwards under internal revenue code description	The federal research and development tax credits begin to expire in 2038 unless previously utilized.
State and Local Jurisdiction [Member]
Income Tax Contingency [Line Items]
Tax loss carryforwards	$ 35,900,000
Net operating loss carryforwards	$ 1,100,000
Net operating loss carryforwards, expire date	Unless previously utilized, certain state net operating losses will begin to expire in 2038. In accordance with the 2017 Tax Cuts and Jobs Act, research and experimental (R&E) expenses under Internal Revenue Code (IRC) Section 174 are required to be capitalized beginning in 2022. R&E expenses are required to be amortized over a period of five years for domestic expenses and 15 years for foreign expenses. The Company has capitalized R&E expenses in its current tax provision pursuant to the IRC Section 174.
Tax credit carryforward	$ 1,300,000
Research and development credit carryforwards under internal revenue code description	The federal research and development tax credits begin to expire in 2038 unless previously utilized.